Apollo Hospitals Enterprise Limited vs Max Healthcare Institute Limited
An objective side-by-side of APOLLOHOSP and MAXHEALTH, both in Healthcare: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-11-05 close
Latest results: APOLLOHOSP Sep 2026 · MAXHEALTH Sep 2026
At a glance
- Apollo Hospitals Enterprise Limited is the larger company by market value, about 1.3 times the size of Max Healthcare Institute Limited.
- On trailing earnings, Apollo Hospitals Enterprise Limited trades at the lower P/E (51.5 against 65.7).
- Apollo Hospitals Enterprise Limited earns the higher return on equity (22.0% against 12.2%).
- Over three years Apollo Hospitals Enterprise Limited has grown profits faster (34% a year against 10%).
- Over the past year the share prices returned +7.5% (APOLLOHOSP) and -20.9% (MAXHEALTH).
| Metric | Apollo Hospitals APOLLOHOSP |
Max Healthcare MAXHEALTH |
|---|---|---|
| Size and price | ||
| Market cap | ₹120,362 Cr | ₹90,713 Cr |
| Share price | ₹8,371.00 | ₹932.00 |
| Valuation | ||
| P/E | 51.50 | 65.72 |
| P/B | 11.35 | 8.01 |
| EV/EBITDA | 30.17 | 38.51 |
| PEG | 1.51 | 6.57 |
| Dividend yield | 0.2% | 0.2% |
| Profitability | ||
| ROE | 22.0% | 12.2% |
| ROCE | 18.0% | 15.0% |
| Operating margin | 15.4% | 26.8% |
| Sales (TTM) | ₹27,742 Cr | ₹9,146 Cr |
| Net profit (TTM) | ₹2,337 Cr | ₹1,380 Cr |
| Growth | ||
| Latest quarter sales YoY | +20.8% | +20.3% |
| Latest quarter profit YoY | +33.5% | -15.6% |
| Sales CAGR 3Y | +15.0% | +22.0% |
| Profit CAGR 3Y | +34.0% | +10.0% |
| Sales CAGR 5Y | +19.0% | +27.0% |
| Profit CAGR 5Y | +78.0% | +60.0% |
| Financial strength | ||
| Debt/Equity | 0.77 | 0.33 |
| Interest cover | 6.44 | 7.63 |
| Ownership | ||
| Promoter holding | 28.0% | 23.7% |
| Promoter change (4 qtrs) | +0.00 pp | -0.03 pp |
| Price performance | ||
| Return 1M | +5.77% | +3.27% |
| Return 3M | -6.05% | -13.70% |
| Return 1Y | +7.46% | -20.92% |
| Return YTD | +18.86% | -10.82% |
| Technical condition | ||
| Technical score | 76 | 55 |
| RS rating (1-99) | 70.00 | 39.00 |
| % vs 200-DMA | +3.09% | -7.89% |
| RSI (14) | 54.98 | 60.71 |
| % from 52-week high | -7.71% | -21.38% |
